Macrogen Inc Total Liabilities
Macrogen Inc total liabilities. Based on the latest financial reports, Macrogen Inc (038290) has total liabilities worth ₩173.25 Billion KRW (≈ $117.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Macrogen Inc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Macrogen Inc (2011–2024)
Total liabilities of Macrogen Inc from 2011 to 2024. This chart illustrates how Macrogen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Macrogen Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Macrogen Inc Competitors by Total Liabilities
The table below lists competitors of Macrogen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korfez Gayrimenkul Yatirim
IS:KRGYO
|
Turkey | TL439.80 Million |
|
Qualicorp Consultoria e Corretora de Seguros S.A
SA:QUAL3
|
Brazil | R$2.08 Billion |
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
India | Rs2.32 Billion |
|
Charoong Thai Wire and Cable Public Company Limited
BK:CTW
|
Thailand | ฿2.04 Billion |
|
Swift Haulage Bhd
KLSE:5303
|
Malaysia | RM998.63 Million |
|
Aiptek International Inc
TW:6225
|
Taiwan | NT$14.51 Million |
|
Agile Group Holdings Limited
F:A8P
|
Germany | €153.51 Billion |
|
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
|
USA | $32.02 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Macrogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 038290 current and non-current assets.
Liquidity & Leverage Metrics
Macrogen Inc Total Liabilities Ratios Explained
Macrogen Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Macrogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Macrogen Inc (2011–2024)
The table below shows the annual total liabilities of Macrogen Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩152.23 Billion ≈ $103.17 Million |
+54.35% |
| 2023-12-31 | ₩98.63 Billion ≈ $66.84 Million |
-2.16% |
| 2022-12-31 | ₩100.80 Billion ≈ $68.31 Million |
+0.27% |
| 2021-12-31 | ₩100.53 Billion ≈ $68.13 Million |
+12.15% |
| 2020-12-31 | ₩89.64 Billion ≈ $60.75 Million |
-20.11% |
| 2019-12-31 | ₩112.20 Billion ≈ $76.04 Million |
+82.48% |
| 2018-12-31 | ₩61.49 Billion ≈ $41.67 Million |
-27.17% |
| 2017-12-31 | ₩84.43 Billion ≈ $57.22 Million |
+9.69% |
| 2016-12-31 | ₩76.97 Billion ≈ $52.16 Million |
+32.26% |
| 2015-12-31 | ₩58.20 Billion ≈ $39.44 Million |
+18.66% |
| 2014-12-31 | ₩49.05 Billion ≈ $33.24 Million |
+77.29% |
| 2013-12-31 | ₩27.66 Billion ≈ $18.75 Million |
-9.02% |
| 2012-12-31 | ₩30.41 Billion ≈ $20.61 Million |
+107.57% |
| 2011-12-31 | ₩14.65 Billion ≈ $9.93 Million |
-- |
About Macrogen Inc
Macrogen, Inc. provides genetic and genomic analysis research services in South Korea and internationally. It offers next generation sequencing (NGS) services, such as whole genome, exome, targeted, transcriptome, metagenome, epigenome, and single cell multi-omics sequencing, as well as whole genome resequencing; and standard, difficult template, and 16S/18S/26S rRNA and ITS region sequencing ser… Read more